Kun has been with Johnson & Johnson Innovative Medicines for the past 10 years and has held a variety of roles on the Market Access team focused on evidence generation and patient access. He is currently in the role of Director for Private Payers and Access Innovation, and he is a passionate advocate about Diversity, Equity and Inclusion initiatives in the industry.

Kun holds a B.Sc. and a Ph.D. in Biochemistry from McGill University and an MBA from the Ivey School of Business at Western University.